An International Publisher for Academic and Scientific Journals
Author Login 
SAS Journal of Medicine | Volume-12 | Issue-11
Clinical Spectrum of Marfan syndrome and Related Phenotypes: A Case Series of Eight Moroccan Patients
Kenza Dafir*, Zakaria Chahbi, Amine Benjelloun Harzimi, Oussama Cherkaoui Rhazouani
Published: Nov. 20, 2026 | 21 18
Pages: 1218-1228
Downloads
Abstract
Background: Marfan syndrome (MFS) is an autosomal dominant connective tissue disorder caused by pathogenic variants in FBN1. The revised Ghent nosology (2010) allows a diagnosis on clinical grounds alone, but molecular confirmation strengthens it and helps exclude overlapping disorders. In Morocco, FBN1 testing is rarely available in public hospitals and remains largely out of pocket. Case Series: We report eight patients (six males, two females; median age 21.5 years, range 18–54) referred for a marfanoid phenotype and assessed without molecular testing. Each patient was classified into one of three categories: MFS fulfilling the revised Ghent criteria, clinically suspected MFS, or Marfan-like phenotype. Four patients fulfilled the Ghent criteria (aortic root dilatation with ectopia lentis, aortic root dilatation with a systemic score ≥ 7, or a first-degree family history with ectopia lentis). The other four had clinically suspected MFS: all had a systemic score ≥ 7 (range 10–15) and one had ectopia lentis, but none had aortic root dilatation or a first-degree relative with MFS. Systemic scores ranged from 9 to 15. Ectopia lentis was found in four patients and aortic root dilatation in two, one of whom also had a type B aortic dissection. Parents were consanguineous in three families. Plasma homocysteine was normal in all patients. Conclusion: Careful application of the Ghent criteria, systematic echocardiography, slit-lamp examination and pedigree analysis allow a reliable classification of patients when genetic testing is unaffordable. Because the features of MFS appear with age, patients with clinically suspected MFS may later fulfil the criteria and require long-term follow-up. Better access to FBN1 testing would confirm the diagnosis in these strongly suspected cases and enable family screening.